This site is intended for healthcare professionals
Industry news

AstraZeneca, MedImmune, and Moderna Therapeutics to collaborate on mRNA therapy

Read time: 1 mins
Last updated:12th Jan 2016
Published:12th Jan 2016
Source: Pharmawand
AstraZeneca, along with its global biologics research and development arm, MedImmune, and Moderna Therapeutics has announced a new collaboration to discover, co-develop and co-commercialise messenger RNA (mRNA) therapeutic candidates for the treatment of a range of cancers. The collaboration is in addition to the agreement announced by the companies in 2013 to develop mRNA Therapeutics for the treatment of cardiovascular, metabolic and renal diseases as well as selected targets in oncology.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.